American Academy of Neurology Annual Meeting

Progress in Neurogenerative Disease Drug Development: Gregory A. Rippon, MD, MS

May 19, 2022

The chief medical partner of neurology, ophthalmology, and internal medicine at Genentech shared his perspective on the steps the field has taken to improve clinical trials and therapies for neurodegenerative diseases such as Alzheimer disease. [WATCH TIME: 3 minutes]

The Future of Tears as a Biomarker for Neurodegenerative Disorders: Mark Lew, MD

May 09, 2022

The director of the Division of Movement Disorders at the USC Keck School of Medicine provided insight on the next steps in how we can expand on tears as a valuable biomarker for neurodegenerative diseases. [WATCH TIME: 4 minutes]

Regenerative Medicine for Neurologic Injury and the Potential of SB623

April 29, 2022

Peter J. McAllister, MD, FAAN, medical director and chief medical officer, New England Center for Neurology and Headache, offered his insight into data from the phase 2 STEMTRA trial in TBI and the trends he’s observed in the field of regenerative medicine.

AAN Annual Meeting 2022: Top Expert Interviews

April 28, 2022

Expert clinicians offer their insight on the associations between stroke and COVID-19, treatment for traumatic brain injury, the latest on aducanumab, priorities for research in migraine, and more, from the 2022 American Academy of Neurology Annual Meeting.